Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

A Dose of Growth for Your Portfolio

By Sam Stovall Listed below are the sub-industries within the S&P Super 1500 that posted six-month (26-week) price performances that were in the top 10% of all 115 sub-industries through July 20, 2001. Each carries the highest S&P Relative Strength Ranking (RSR) of "5." (Click here to learn more about the RSRs.)

Last week, the Reinsurance and Steel industries dropped down to a six-month RSR of "4", replaced by Gold and Health Care Distributors & Services. The latter group is showing consistency across the board with an RSR of 5 during the past three, six and 12 months. And Rob Gold, S&P's Health Care Facilities, Services and Medical Devices analyst, is positive on the group's prospects.

Why? "Drug distributors are likely to benefit from the continued introduction of a steady stream of higher-priced new drugs," notes Gold. He also cites a decline in drug chain consolidations. As a result of these factors, Gold believes the industry index is likely to outperform the market over the next year.

As for the drug wholesalers, they "should be propelled by strong underlying industry fundamentals," according to the analyst. Gold thinks that sales should continue to grow at a better than 10% rate, due to good consumption trends, higher priced new drugs, an aging population and continued drug price inflation -- which has historically averaged twice the rise in the consumer price index (CPI). Given that a typical wholesaler's prescription drug sales account for more than 85% of its total sales, "new drug developments should help the industry continue its strong top-line growth trends," he adds.

Gold thinks the wholesalers should get a boost from rapid consolidation over the past few years, enabling the resultant companies to increase cost efficiencies and improve purchasing power.




Auto Parts & Equipment

Superior Industries (SUP)

Construction Materials

Texas Industries (TXI)

Environmental Svcs.

Waste Management (WMI)


Barrick Gold (ABX)

Health Care Distrs. & Svcs.

Lincare Holdings (LNCR)

Health Care Facilities



Lennar Corp. (LEN)

Leisure Products


Metal & Glass Containers

Pactiv Corp.(PTV)

Oil & Gas Refining/Mktg

Sunoco Inc.(SUN)

Trading Cos. & Distributors

Fastenal Co. (FAST)

Stovall is Senior Sector Strategist for Standard & Poor's

blog comments powered by Disqus